CNS Therapies Contribute Rising Share Of Breakthrough Designations

Breakthrough program could speed first treatments for tardive dyskinesia, primary progressive multiple sclerosis, and Parkinson's psychosis to market, along with new fast-acting approaches to treatment-resistant depression.